Anthropic launches Claude Science workbench for researchers

Anthropic on Tuesday began rolling out Claude Science, an AI-powered workbench designed to give scientists a single environment for research across biology, chemistry, genomics, and drug discovery. The product was announced at "The Briefing: AI for Science," a live event in San Francisco featuring pharmaceutical executives and research leaders.anthropic

The launch represents Anthropic's most direct play yet to embed its AI models into the daily workflow of laboratory scientists. Inductive Bio, an AI drug discovery company, said Tuesday it had joined Anthropic's life sciences ecosystem with a connector that makes its ADMET prediction models accessible within "Claude and Claude Science, Anthropic's AI workbench for scientists".basecamp-research

Building on a Life Sciences Foundation

Claude Science extends Anthropic's push into scientific research that began in October 2025 with Claude for Life Sciences, which connected Claude to platforms like Benchling, PubMed, and 10x Genomics for tasks ranging from hypothesis generation to regulatory document drafting. That initial offering drew partnerships with Novo Nordisk ↗ 3.40% for clinical study documentation and with the Allen Institute for the development of autonomous AI agents in bioscience.alleninstitute+3

Basecamp Research, a biotech company backed by investors including the vice-chairman of Roche, confirmed that its EDEN foundation models for antibiotic peptide design and immunogenicity prediction are now available through Claude. The event's speaker lineup underscored the scale of Anthropic's pharma ambitions, with Vas Narasimhan, CEO of Novartis and an Anthropic board member, and Chris Boerner, CEO of Bristol Myers Squibb, among those presenting. Bristol Myers Squibb in May announced a deal to deploy Claude across its workforce of more than 30,000 employees for research, clinical development, and corporate functions.basecamp-research+3

A Crowded Field for Scientific AI

The announcement arrives as competition heats up in the scientific AI workbench space. Just a day earlier, Databricks and Nvidia ↘ 1.39% launched their own Genesis Workbench aimed at AI scientists. Anthropic's Claude Fable 5 model, released earlier in June, was already marketed for drug discovery applications, with the company claiming it "accelerated aspects of the drug design process by around ten times".pharmaphorum+1

Anthropic's event, which featured product demonstrations during its keynote program running from 10:00 AM to 11:40 AM PDT, also included sessions from Aviv Regev, head of research and early development at Genentech, and Eric Kauderer-Abrams, Anthropic's head of life sciences.anthropic